CJJ300 |
| Catalog No.GC68875 |
CJJ300 est un inhibiteur du facteur de croissance transformant bêta (TGF-β), avec une valeur IC50 de 5,3 µM. CJJ300 inhibe la signalisation TGF-β en bloquant la formation du complexe de signalisation TGF-β-TβR-I-TβR-II.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1807631-83-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for CJJ300
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for CJJ300
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *